Threat-Related Stimulus Exposure for Stuttering
Trial Summary
What is the purpose of this trial?
The goal of this clinical trial is to examine whether stuttering is associated with a tendency to attend more quickly or for longer durations to threat-related information in the environment (threat-related attention bias). The main questions it aims to answer are: Do adults who stutter, relative to adults who do not stutter, attend to threat-related stimuli more than neutral information? Are attentional biases observed across different types of threat or are they specific to threats related to stuttering experiences? Do measures of attention bias explain individual differences in psychological reactions among adults who stutter?
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, if you have a significant medical history or certain psychological conditions, you may not be eligible to participate.
What data supports the effectiveness of the treatment Threat-related stimulus exposure for stuttering?
Is threat-related stimulus exposure safe for humans?
How does the Threat-Related Stimulus Exposure treatment for stuttering differ from other treatments?
Threat-Related Stimulus Exposure is unique because it uses exposure to threat-related stimuli, like unpredictable screams, to potentially reduce anxiety associated with stuttering. This approach is different from traditional speech therapy as it focuses on managing anxiety rather than directly modifying speech patterns.78101112
Eligibility Criteria
This trial is for adults who identify as stutterers, with a mild degree of stuttering or more. They must have normal color vision, speak English primarily, and have at least average nonverbal intelligence and expressive language ability. Excluded are those with significant medical conditions, psychological disorders, reading difficulties, other speech/language disorders besides stuttering, neurological injuries or high scores on depression/anxiety/ADHD scales.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Experimental Tasks
Participants complete three experimental tasks: free-viewing task, dot-probe task, and emotional Stroop task to measure attention bias
Follow-up
Participants are monitored for safety and effectiveness after experimental tasks
Treatment Details
Interventions
- Threat-related stimulus exposure
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Memphis
Lead Sponsor
University of Alabama, Tuscaloosa
Collaborator